Global Amniotic Products Market Outlook, 2020-2025 - Cryopreserved Amniotic Membranes and Wound Care Applications Present Lucrative Opportunities

News provided by

May 28, 2020, 05:45 ET

DUBLIN, May 28, 2020 /PRNewswire/ -- The "Amniotic Products Market by Type [Amniotic Membranes (Cryopreserved Amniotic Membranes, Dehydrated Amniotic Membranes), Amniotic Suspensions], Application (Wound Care, Ophthalmology, Orthopedics), End User (Hospital, ASCs) - Global Forecast to 2025" report has been added to ResearchAndMarkets.com's offering.

The global amniotic products market is projected to reach USD 1,095.3 million by 2025 from USD 748.2 million in 2020, at a CAGR of 7.9%.

Growth in the target patient population and awareness programs for wound care treatment and management are expected to drive the overall growth of the amniotic products market.

Market growth is largely driven by factors such as growth in the target patient population, the rising incidence of burn injuries, awareness programs for wound care treatment and management, and the rise in venture capital funding and government investments. The emerging economies and the implementation of the 21st Century Cures Act are expected to provide a wide range of growth opportunities for players in the market. On the other hand, the complications and limitations associated with the use of amniotic membranes are expected to challenge market growth to a certain extent.

The cryopreserved amniotic membranes segment is expected to dominate the market during the forecast period.

On the basis of type, amniotic membranes are categorized into cryopreserved amniotic membranes and dehydrated amniotic membranes. Both membrane types come in a variety of tissue thicknesses and sizes, depending on clinical needs. Cryopreserved amniotic membranes commanded the largest share of the global amniotic membranes market in 2019. The cryopreservation technique retains extracellular matrix components, such as growth factors, collagen, heavy-chain hyaluronic acids, and fibronectin, all of which promote anti-inflammatory effects and healing. These characteristics of cryopreserved amniotic membranes drive market growth.

Wound care application segment to witness the highest growth in the amniotic products market during the forecast period.

Based on application, the amniotic products market is categorized into wound care, ophthalmology, orthopedics, and other applications. Wound care was the largest application segment in the amniotic products market in 2019 and is expected to grow at the highest CAGR during the forecast period. Growth in this market is largely driven by the rising prevalence of diabetic foot ulcers, venous leg ulcers, surgical & traumatic wounds, and burn injuries.

North America to dominate the market during the forecast period.

Geographically, the amniotic products market is segmented into North America, Europe, the Asia Pacific, and the Rest of the World. In 2019, North America accounted for the largest share of the amniotic products market. The large share of this region can be attributed to the increasing geriatric population, the strong presence of key market players of amniotic products, the high prevalence of target diseases, and rising awareness about advanced treatment options.

Key Topics Covered

1 Introduction

2 Research Methodology

3 Executive Summary

4 Premium Insights
4.1 Amniotic Products Market Overview
4.2 Amniotic Membranes Market, by Type, 2020 Vs. 2025 (USD Million)
4.3 Amniotic Products Market, by Application, 2020 Vs. 2025 (USD Million)
4.4 Amniotic Products Market, by End User, 2019
4.5 Amniotic Products Market: Geographic Snapshot

5 Market Overview
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Growth in the Target Patient Population
5.2.1.2 Rising Incidence of Burn Injuries
5.2.1.3 Awareness Programs for Wound Care Treatment and Management
5.2.1.4 Rise in Venture Capital Investment and Government Funding
5.2.2 Opportunities
5.2.2.1 Emerging Economies
5.2.2.2 Implementation of the 21st Century Cures Act (US)
5.2.3 Challenges
5.2.3.1 Complications and Limitations Associated with the Use of Amniotic Membranes

6 Amniotic Products Market, by Type
6.1 Introduction
6.2 Amniotic Membranes
6.2.1 Cryopreserved Amniotic Membranes
6.2.1.1 Cryopreserved Amniotic Membranes to Dominate the Market during the Forecast Period
6.2.2 Dehydrated Amniotic Membranes
6.2.2.1 Logistical Advantages of Dehydrated Amniotic Membranes Over Cryopreserved Amniotic Membranes to Drive Market Growth
6.3 Amniotic Suspensions
6.3.1 Anti-Adhesive, Anti-Inflammatory, and Antimicrobial Properties of Amniotic Suspensions to Drive Growth

7 Amniotic Products Market, by Application
7.1 Introduction
7.2 Wound Care
7.2.1 Wound Care Applications to Account for the Largest Share of the Amniotic Products Market
7.3 Orthopedics
7.3.1 Benefits Offered by Amniotic Products for Orthopedic Applications to Drive Market Growth
7.4 Ophthalmology
7.4.1 Lightweight, Thin, and Elastic Nature of Amniotic Membranes Makes Them Suitable for USe in Ophthalmology
7.5 Other Applications

8 Amniotic Products Market, by Region
8.1 Introduction
8.2 North America
8.2.1 US
8.2.1.1 the US to Dominate the North American Amniotic Products Market during the Forecast Period
8.2.2 Canada
8.2.2.1 Rising Prevalence of Target Diseases to Drive Market Growth
8.3 Europe
8.3.1 UK
8.3.1.1 the UK Accounted for the Largest Share of the European Amniotic Products Market in 2019
8.3.2 Germany
8.3.2.1 Increasing Incidence of Diabetes to Drive Market Growth in Germany
8.3.3 France
8.3.3.1 Rising Government Support to Drive the Market Demand for Amniotic Products in France
8.3.4 Rest of Europe
8.4 Asia Pacific
8.4.1 China
8.4.1.1 China to Dominate the Asia Pacific Market during the Forecast Period
8.4.2 Japan
8.4.2.1 Growing Geriatric Population to Drive Market Growth in Japan
8.4.3 RoAPAC
8.5 RoW

9 Competitive Landscape
9.1 Overview
9.2 Market Share Analysis, 2018
9.3 Competitive Scenario
9.3.1 Partnerships, Agreements, and Collaborations
9.3.2 Product Launches & Approvals
9.3.3 Expansions
9.3.4 Acquisitions
9.4 Competitive Leadership Mapping (2019)
9.4.1 Vendor Inclusion Criteria
9.4.2 Visionary Leaders
9.4.3 Innovators
9.4.4 Dynamic Differentiators
9.4.5 Emerging Companies

10 Company Profiles
10.1 Mimedx
10.2 Smith & Nephew
10.3 Organogenesis Inc.
10.4 Integra Lifesciences Corporation
10.5 Stryker Corporation
10.6 Wright Medical Group
10.7 Applied Biologics
10.8 Celularity, Inc.
10.9 Katena Products, Inc.
10.10 Lucina Biosciences
10.11 Next Biosciences
10.12 Skye Biologics Inc.
10.13 Surgenex
10.14 Tissuetech, Inc.
10.15 Ventris Medical, LLC
10.16 Stimlabs LLC
10.17 Vivex Biologics, Inc.
10.18 Lifecell International Pvt. Ltd.
10.19 Nuvision Biotherapies Limited
10.20 Genesis Biologics

For more information about this report visit https://www.researchandmarkets.com/r/bs9wgc

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets